Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

BACKGROUND: Colchicine has been proposed as a COVID-19 treatment. AIM: To determine whether colchicine reduces time to recovery and COVID-19-related admissions to hospital and/or deaths among people in the community. DESIGN AND SETTING: Prospective, multicentre, open-label, multi-arm, randomised, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorward, Jienchi, Yu, Ly-Mee, Hayward, Gail, Saville, Benjamin R, Gbinigie, Oghenekome, Van Hecke, Oliver, Ogburn, Emma, Evans, Philip H, Thomas, Nicholas PB, Patel, Mahendra G, Richards, Duncan, Berry, Nicholas, Detry, Michelle A, Saunders, Christina, Fitzgerald, Mark, Harris, Victoria, Shanyinde, Milensu, de Lusignan, Simon, Andersson, Monique I, Butler, Christopher C, Hobbs, FD Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037186/
https://www.ncbi.nlm.nih.gov/pubmed/35440469
http://dx.doi.org/10.3399/BJGP.2022.0083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037186/
https://www.ncbi.nlm.nih.gov/pubmed/35440469
http://dx.doi.org/10.3399/BJGP.2022.0083

Ejemplares similares